Factors associated with severe or fatal clinical manifestations of SARS‐CoV‐2 infection after receiving the third dose of vaccine

BACKGROUND: Little is known about vulnerability to severe COVID‐19 illness after vaccination completion with three doses of vaccine against COVID‐19. OBJECTIVES: To identify individual features associated with increased risk of severe clinical manifestation of SARS‐CoV‐2 infections after receiving t...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrao, Giovanni, Franchi, Matteo, Cereda, Danilo, Bortolan, Francesco, Leoni, Olivia, Jara, Jose, Valenti, Giuseppina, Pavesi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539163/
https://www.ncbi.nlm.nih.gov/pubmed/35943414
http://dx.doi.org/10.1111/joim.13551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539163/
https://www.ncbi.nlm.nih.gov/pubmed/35943414
http://dx.doi.org/10.1111/joim.13551

Ejemplares similares